Nifurtimox
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101673This classification denotes an antiprotozoal agent with the molecular formula C10H13N3O5S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier M84I3K7C2O, chemically known as 4-thiomorpholinamine, 3-methyl-n-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide but more generally known as nifurtimox, which bears U.S. National Institutes of Health Compound Identifier 6842999. The European Medicines Agency schedules Nifurtimox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09280MIG. The term NIFURTIMOX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 23, No. 10 1969, List 9). The World Health Organization schedules nifurtimox in its Anatomical Therapeutic Chemical (ATC) Classification. NIFURTIMOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-].
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.